application of genomic technologies in assessing gene ... · metabonomics(or metabolomics) ......

38
Application of Genomic Application of Genomic Technologies in Assessing Technologies in Assessing Gene Gene - - Environment Environment Interactions: Implications for Interactions: Implications for Occupational Health Occupational Health David C. Christiani, MD, MPH, MS David C. Christiani, MD, MPH, MS

Upload: others

Post on 20-Jul-2020

8 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Application of Genomic Application of Genomic Technologies in Assessing Technologies in Assessing

GeneGene--Environment Environment Interactions: Implications for Interactions: Implications for

Occupational HealthOccupational Health

David C. Christiani, MD, MPH, MSDavid C. Christiani, MD, MPH, MS

Page 2: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Grant SupportGrant Support

NIH (NIEHS) grants ESNIH (NIEHS) grants ES0986009860 and ES00002 and ES00002

NIH (NIEHS) T32 07069NIH (NIEHS) T32 07069

CDC (NIOSH) CDC (NIOSH) T42 OH008416T42 OH008416

Page 3: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

DisclosuresDisclosures

No disclosures to declareNo disclosures to declare

Page 4: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

In 2003 scientists in the Human In 2003 scientists in the Human Genome Project obtained the DNA Genome Project obtained the DNA sequence of the 3 billion base pairs sequence of the 3 billion base pairs

making up the human genomemaking up the human genome

www.ornl.gov/hgmis/posters/

Page 5: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

What we learnedWhat we learned

The human genome is nearly the same (99.9%) in all The human genome is nearly the same (99.9%) in all peoplepeople

Only about 2% of the human genome contains genes, Only about 2% of the human genome contains genes, which are the instructions for making proteinswhich are the instructions for making proteins

Humans have an estimated 30,000 genes; the functions Humans have an estimated 30,000 genes; the functions of more than half of them are unknownof more than half of them are unknown

www.ornl.gov/hgmis/posters/

Page 6: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

www.ornl.gov/hgmis/posters/

Page 7: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

National Research Council Report

Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment

Public Release October 9, 2007

Page 8: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Committee MembershipDavid C. Christiani (Chair), Harvard School of Public Health, Boston, MACynthia A. Afshari, Amgen, Inc.,Thousand Oaks, CAJohn M. Balbus, Environmental Defense, Washington, DCJames S. Bus, The Dow Chemical Company, Midland, MIBruce F. Demple, Harvard School of Public Health, Boston, MALinda E. Greer, Natural Resources Defense Council, Washington, DCSharon L.R. Kardia, University of Michigan, Ann ArborGeorge D. Leikauf, University of Pittsburgh Graduate School of Public Health, PA

Daniel C. Liebler, Vanderbilt University School of Medicine, Nashville, TNGary E. Marchant, Arizona State University College of Law, TempeJohn Quackenbush, Harvard School of Public Health, Boston, MAKenneth S. Ramos, University of Louisville, KYMark A. Rothstein, University of Louisville School of Medicine, KYRaymond E. Stoll, Stoll & Associates, LLC, Storrs-Mansfield, CTRoger G. Ulrich, Calistoga Pharmaceuticals Inc., Seattle, WAHelmut Zarbl, University of Medicine and Dentistry of New Jersey, Piscataway

Page 9: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Toxicogenomics: DefinitionToxicogenomics: Definition

The application of genomic technologies (e.g., genetics, The application of genomic technologies (e.g., genetics, genome sequence analysis, gene expression profiling, genome sequence analysis, gene expression profiling, proteomics, metabolomics, and related approaches) to proteomics, metabolomics, and related approaches) to study the adverse effects of environmentallystudy the adverse effects of environmentally--released released chemicals and pharmaceutical agents on human health chemicals and pharmaceutical agents on human health and the environment.and the environment.

Page 10: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

What can Toxicogenomics do?What can Toxicogenomics do?

Provide insights into geneProvide insights into gene--environmental interactions environmental interactions and the response of biological pathways and networks and the response of biological pathways and networks to stress.to stress.

Lead to information that is more discriminating, Lead to information that is more discriminating, predictive, and sensitive than that currently used to predictive, and sensitive than that currently used to evaluate toxic exposure or predict effects on human evaluate toxic exposure or predict effects on human health.health.

Page 11: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Assessing ToxicityAssessing Toxicity

Traditionally deals with phenotypic changes in an Traditionally deals with phenotypic changes in an organism that result from exposure to chemical, organism that result from exposure to chemical, biological or physical agents.biological or physical agents.

These changes maybe reversible (e.g. transient skin These changes maybe reversible (e.g. transient skin reactions) or irreversible (e.g. cell death, mutation), reactions) or irreversible (e.g. cell death, mutation), leading to chronic diseases such as fibrosis or cancer.leading to chronic diseases such as fibrosis or cancer.

Page 12: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Types of StudiesTypes of Studies

Whole animalWhole animalIsolated organ preparationsIsolated organ preparationsCell/tissue cultureCell/tissue cultureEvaluating exposure/doseEvaluating exposure/doseChronic exposures (Epi studies cohort; caChronic exposures (Epi studies cohort; ca--co)co)Panel studies Panel studies –– exposure chambers, field labsexposure chambers, field labs

Page 13: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Molecular EpidemiologyMolecular Epidemiology

Page 14: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Sequencing & Genotyping TechnologiesSequencing & Genotyping Technologies

Allow the simultaneous assessment of multiple variants Allow the simultaneous assessment of multiple variants across the whole genome, in large populations, rather across the whole genome, in large populations, rather than just single or several gene polymorphisms. than just single or several gene polymorphisms.

GWAS now feasible for population studies GWAS now feasible for population studies –– not not hypothesishypothesis--driven, but provides opportunity for driven, but provides opportunity for pathway analyses.pathway analyses.

Page 15: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

ToxicogenomicsToxicogenomics

ExposureExposure--response integrated measures in disease development response integrated measures in disease development

Early diagnosis

Signature pattern

(Novel biomarkers)

Predict susceptibility

Monitor progression

Genomics

Page 16: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Transcriptomics Transcriptomics (or gene expression profiling)(or gene expression profiling)

Measures RNA expression in a parallel assay system, Measures RNA expression in a parallel assay system, usually using microarraysusually using microarrays

Array technology for transcriptomics has enabled the Array technology for transcriptomics has enabled the analysis of complex, multigene systems and their analysis of complex, multigene systems and their responses to environmental perturbations. responses to environmental perturbations.

Page 17: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

TranscriptomicsTranscriptomics

Transcriptomics have also driven the growth of Transcriptomics have also driven the growth of ““systems biologysystems biology”” which brings together global which brings together global measures to define biological states on the basis of measures to define biological states on the basis of integrated responses. integrated responses.

PrinciplePrinciple-- genes exhibiting similar expression patterns genes exhibiting similar expression patterns my be related functionally and under common genetic my be related functionally and under common genetic control mechanisms. control mechanisms.

Page 18: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Occupational/environmental CardioOccupational/environmental Cardio--pulmonary Disorderspulmonary Disorders

Active union Active union membership of the membership of the Local 29, Local 29, International International Brotherhood of Brotherhood of Boilermakers, IronBoilermakers, Iron--Ship Builders, Ship Builders, Blacksmiths and Blacksmiths and ForgersForgers

Page 19: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

BackgroundBackground

Particulate exposure is associated with increases in Particulate exposure is associated with increases in morbidity and mortality from respiratory and morbidity and mortality from respiratory and cardiovascular diseasescardiovascular diseases..

Welding process generates high levels of metal fume Welding process generates high levels of metal fume containing respirable particles. containing respirable particles.

Systemic alterations induced by inhaled particulates:Systemic alterations induced by inhaled particulates:Change HRVChange HRV

Release of inflammatory cytokines subsequent to pulmonary Release of inflammatory cytokines subsequent to pulmonary inflammationinflammation

Page 20: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Exploratory StudyExploratory Study----HypothesisHypothesis

Exposure to particulate air pollutants (metal fume) induces systemic inflammation.

The systematic inflammation can be assessed in peripheral white blood cells by monitoring gene expression using microarrays pre-and post-exposure.

Page 21: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Gene Expression Profiling in Humans Following Gene Expression Profiling in Humans Following Toxicant ExposureToxicant Exposure

NS: non-smoker; S: Smoker;

PM2.5: average exposure between 6 hrs time point and baseline

Page 22: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Microarray HybridizationMicroarray Hybridization

Microarray Core Facility of Dana-Farber Cancer Institute/ Harvard Cancer Center

Affymetrix U133A GeneChips (22,215 probe sets)

Batch Analysis (baseline and post-shift samples)

Normalization and calculation of expression values (dChip Analyzer 2006)

The Detection Call (Affymetrix MAS 5)the dichotomous data of absolute gene expression status, which was either expressed (Present Call) or non-expressed (Absent Call).

Page 23: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

-0.6

-0.4

-0.2

0

0.2

0.4

0.6

-0.6 -0.4 -0.2 0 0.2 0.4 0.6

Exposure Period, Fold Change -1

Pos

t-Exp

osur

e P

erio

d, F

old

Cha

nge

- 1

Y = -0.9323x + 0.004 R2 = 0.8189

Acute metal exposure can cause transient gene expression alterations in whole blood total RNA

Page 24: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

ResultsResultsSixty-five genes changed significantly from baseline in both the exposure period (6 hrs.) and the post-exposure period (24 hrs.) with opposite directions of expression changes. Red triangles represent genes significantly different from baseline expression in both the exposure and post-exposure periods; Green diamonds represent genes that tested significantly only in the exposure period; Yellow squares represent genes tested significantly only in the post-exposure period.

Page 25: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

-0.6

-0.4

-0.2

0

0.2

0.4

0.6

-0.6 -0.4 -0.2 0 0.2 0.4 0.6

Exposure Period, Fold Change -1

Pos

t-Exp

osur

e P

erio

d, F

old

Cha

nge

- 1

Y = -0.9323x + 0.004 R2 = 0.8189

Acute metal exposure can cause transient gene expression alterations in whole blood total RNA

Page 26: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Results Results -- 11

The observation of genes clustered in the functional pathways related to inflammatory and immune responses support the hypothesis that metal particulate induces systemic inflammation.

Using toxicogenomic techniques in epidemiologic studies of human exposure effects is feasible.

Wang et. al., Env Health Perspectives, 2005

Page 27: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Results Results -- 22

Acute metal exposure causes transient gene expression alterations in whole blood total RNA using a repeated measure design.

The time course of expression alterations was consistent with the results of wbc counts, which rose after exposure.

Smoking alters expression profiles in the whole blood total RNA and is a confounding factor.

At lower exposure levels, non-smokers had larger short-term fold changes than did smokers, and these changes were related to metal fume exposure level.

Page 28: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

ProteomicsProteomics

The study of collections of proteins in living The study of collections of proteins in living systems. systems.

Since the same proteins may exist in multiple Since the same proteins may exist in multiple modified and variant forms, proteomes are modified and variant forms, proteomes are complex than the genomes and transcriptomes.complex than the genomes and transcriptomes.

Page 29: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

ProteomicsProteomics

Use mass spectrometry (MS) and microarray Use mass spectrometry (MS) and microarray technologies to resolve and identify the technologies to resolve and identify the components of complex protein mixtures, to components of complex protein mixtures, to identify and map protein modifications, to identify and map protein modifications, to characterize protein functional associations, and characterize protein functional associations, and to compare proteomic changes quantitatively in to compare proteomic changes quantitatively in different biological states.different biological states.

Page 30: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Proteomic Profiling in the Sera of Workers Proteomic Profiling in the Sera of Workers Occupationally Exposed to Arsenic and LeadOccupationally Exposed to Arsenic and Lead

Metal workers: 46 male smelter workers with higher Metal workers: 46 male smelter workers with higher urine As and/or blood Pburine As and/or blood Pb

Controls: 45 age matched male officersControls: 45 age matched male officers

SurfaceSurface--Enhanced Laser Desorption/Ionization TimeEnhanced Laser Desorption/Ionization Time--OfOf--Flight Mass Spectrometer (SELDIFlight Mass Spectrometer (SELDI--TOFTOF--MS)MS)

The WCX2 (weak cationic exchange) ProteinChip The WCX2 (weak cationic exchange) ProteinChip

Zhai et al, Biometals, 2005Zhai et al, Biometals, 2005

Page 31: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Serum protein profiles of metal worker and control. Serum protein profiles of metal worker and control. AbscissaAbscissa-- m/z in Daltons; Ordinatem/z in Daltons; Ordinate--relative intensityrelative intensity

5000 5250 5500 5750 6000 6250

5000 5250 5500 5750 6000 6250

1020116320-E

0

20

40

60

5338.6+H

5635.9+H5906.0+H

6111.7+H

5000 5250 5500 5750 6000 6250

5000 5250 5500 5750 6000 6250

1020116320-F

0

20

40

60

A. Metal worker

B. Control

Page 32: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

ROC curve analysis of the 5 selected protein markers (B, C, D, EROC curve analysis of the 5 selected protein markers (B, C, D, E, F) , F) and composite index (A) and composite index (A) Zhai et al, Biometals, 2005Zhai et al, Biometals, 2005

0

0.2

0.4

0.6

0.8

1

0 0.2 0.4 0.6 0.8 1

1-Specificity

Sen

sitiv

ity

0

0.2

0.4

0.6

0.8

1

0 0.2 0.4 0.6 0.8 1

1-Specificity

Sens

itivi

ty

0

0.2

0.4

0.6

0.8

1

0 0.2 0.4 0.6 0.8 1

1-Specificity

Sens

itivi

ty

0

0.2

0.4

0.6

0.8

1

0 0.2 0.4 0.6 0.8 1

1-SpecificitySe

nsiti

vity

0

0.2

0.4

0.6

0.8

1

0 0.2 0.4 0.6 0.8 1

1-Specificity

Sen

sitiv

ity

0

0.2

0.4

0.6

0.8

1

0 0.2 0.4 0.6 0.8 1

1-Specificity

Sens

itivi

ty

A. Composite index, AUC=0.93 B. M2097, AUC=0.63

C. M2953, AUC=0.61 D. M3941, AUC=0.76

E. M5338, AUC=0.82 F. M5639, AUC=0.69

Multiple serum proteomic markers could achieve higher sensitivity and specificity than individual marker for detection of metal mixture exposure

Page 33: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

MetabonomicsMetabonomics (or metabolomics)(or metabolomics)

The study of small molecule components of biological The study of small molecule components of biological systems, which are the products of metabolic processes. systems, which are the products of metabolic processes.

Since metabolites reflect the activities of RNASince metabolites reflect the activities of RNA’’s s proteins and genes that encode them, metabonomics proteins and genes that encode them, metabonomics allow functional assessment of diseases, drug and allow functional assessment of diseases, drug and chemical toxicity. chemical toxicity.

Page 34: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

MetabonomicsMetabonomics

Use NMR spectroscopy and mass spectrometry MS, Use NMR spectroscopy and mass spectrometry MS, and can assess simultaneously dozens to thousands of and can assess simultaneously dozens to thousands of compounds in biofluids such as urine or in cell and compounds in biofluids such as urine or in cell and tissue extracts. tissue extracts. Attractive potential for using urine, saliva, sputum as Attractive potential for using urine, saliva, sputum as nonnon--invasive media for analyses of biomarkers of invasive media for analyses of biomarkers of exposure, early responses and early disease detection.exposure, early responses and early disease detection.

Page 35: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Identification of diseaseIdentification of disease-- and nutrientand nutrient--related related metabolic fingerprints in osteoarthritic Guinea pigs. metabolic fingerprints in osteoarthritic Guinea pigs.

Principal component discriminant analysis (PCDA) score plots visualizing disease-related differences in NMR spectra. Lamers et al. J Nutr. 2003Lamers et al. J Nutr. 2003

Page 36: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

ConclusionsConclusions

New New ““omicomic”” techinologies generally described techinologies generally described generally as generally as ““ToxicogenomicsToxicogenomics”” have the potential for have the potential for moving environmental health sciences and moving environmental health sciences and pharmacology into a new stage of discovery. However, pharmacology into a new stage of discovery. However, we are only at the threshold and a new initiative on the we are only at the threshold and a new initiative on the scale of the Human Genome Project ( e.g. a Human scale of the Human Genome Project ( e.g. a Human Toxicogenomic Initiative) is needed to realize this Toxicogenomic Initiative) is needed to realize this potentialpotential. . (NAS/NRC report, 10/9/2007)(NAS/NRC report, 10/9/2007)

Page 37: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Research TeamResearch Team

RecruitmentRecruitmentAndrea ShaferAndrea Shafer

Marcia ChertokMarcia Chertok

LaboratoryLaboratoryLi Su Li Su

Ema RodriguesEma Rodrigues

Ed FoxEd Fox

Data management and Data management and data analysisdata analysis

Lucy Ann PrincipeLucy Ann PrincipeSal MucciSal MucciRichard RiveraRichard Rivera--MassaMassaJanna FrelichJanna Frelich

Page 38: Application of Genomic Technologies in Assessing Gene ... · Metabonomics(or metabolomics) ... metabonomics allow functional assessment of diseases, drug and allow functional assessment

Doctoral StudentsDoctoral StudentsShona FangShona FangJenn CavallariJenn Cavallari

PostPost--doctoraldoctoralFellows/Res ScientistsFellows/Res Scientists

Mike WangMike Wang

Rihong ZhaiRihong Zhai

HSPH collaboratorsHSPH collaborators

Louise RyanLouise Ryan

Xihong LinXihong Lin

Donna NeubergDonna Neuberg